These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21499681)

  • 1. Stabilization of human urine doping control samples: a current opinion.
    Tsivou M; Georgakopoulos DG; Dimopoulou HA; Koupparis MA; Atta-Politou J; Georgakopoulos CG
    Anal Bioanal Chem; 2011 Aug; 401(2):553-61. PubMed ID: 21499681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doping control container for urine stabilization: a pilot study.
    Tsivou M; Giannadaki E; Hooghe F; Roels K; Van Gansbeke W; Garribba F; Lyris E; Deventer K; Mazzarino M; Donati F; Georgakopoulos DG; Van Eenoo P; Georgakopoulos CG; de la Torre X; Botrè F
    Drug Test Anal; 2017 May; 9(5):699-712. PubMed ID: 27497113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of human urine doping control samples: IV. Human chorionic gonadotropin.
    Tsivou M; Dimopoulou HA; Georgakopoulos DG; Koupparis MA; Atta-Politou J; Georgakopoulos CG
    Anal Bioanal Chem; 2010 Oct; 398(3):1313-8. PubMed ID: 20658279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization of human urine doping control samples: III. Recombinant human erythropoietin.
    Tsivou M; Dimopoulou HA; Leontiou IP; Georgakopoulos DG; Koupparis MA; Atta-Politou J; Georgakopoulos CG
    Clin Chim Acta; 2010 Mar; 411(5-6):448-52. PubMed ID: 19958754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of human urine doping control samples: II. microbial degradation of steroids.
    Tsivou M; Livadara D; Georgakopoulos DG; Koupparis MA; Atta-Politou J; Georgakopoulos CG
    Anal Biochem; 2009 May; 388(1):146-54. PubMed ID: 19232313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence flow cytometer to determine urine particle reference intervals in doping control samples.
    Robinson N; Sottas PE; Saugy M
    Forensic Sci Int; 2011 Dec; 213(1-3):95-100. PubMed ID: 21889276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of a marker substance for monitoring in situ 17-keto modifications in endogenous steroids caused by microbiological contamination.
    Pfeffer S; Gmeiner G; Gärtner P
    Drug Test Anal; 2022 Nov; 14(11-12):1871-1876. PubMed ID: 35128824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doping control analysis of recombinant human erythropoietin, darbepoetin alfa and methoxy polyethylene glycol-epoetin beta in equine plasma by nano-liquid chromatography-tandem mass spectrometry.
    Yu NH; Ho EN; Wan TS; Wong AS
    Anal Bioanal Chem; 2010 Apr; 396(7):2513-21. PubMed ID: 20148243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin (EPO) immunoaffinity columns--a powerful tool for purifying EPO and its recombinant analogues.
    Dehnes Y; Lamon S; Lönnberg M
    J Pharm Biomed Anal; 2010 Dec; 53(4):1028-32. PubMed ID: 20656433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External calibration in gas chromatography-combustion-isotope ratio mass spectrometry measurements of endogenous androgenic anabolic steroids in sports doping control.
    Kioussi MK; Angelis YS; Cawley AT; Koupparis M; Kazlauskas R; Brenna JT; Georgakopoulos CG
    J Chromatogr A; 2011 Aug; 1218(33):5675-82. PubMed ID: 21752385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of athletes` hyperhydration on the urinary 'steroid profile' markers in doping control analysis.
    Athanasiadou I; Kraiem S; Al-Sowaidi S; Al-Mohammed H; Dbes N; Al-Yazedi S; Samsam W; Mohamed-Ali V; Dokoumetzidis A; Alsayrafi M; Valsami G; Georgakopoulos C
    Drug Test Anal; 2018 Sep; 10(9):1458-1468. PubMed ID: 29745045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GC-C-IRMS in routine doping control practice: 3 years of drug testing data, quality control and evolution of the method.
    Polet M; Van Eenoo P
    Anal Bioanal Chem; 2015 Jun; 407(15):4397-409. PubMed ID: 25503937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments in doping testing for erythropoietin.
    Reichel C
    Anal Bioanal Chem; 2011 Aug; 401(2):463-81. PubMed ID: 21637931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of human chorionic gonadotropin (hCG): application of routine immunological methods for initial testing and confirmation analysis in doping control.
    Kuuranne T; Ahola L; Pussinen C; Leinonen A
    Drug Test Anal; 2013 Aug; 5(8):614-8. PubMed ID: 23303576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of reference materials in doping-control analysis.
    Mackay LG; Kazlauskas R
    Anal Bioanal Chem; 2011 Aug; 401(2):483-92. PubMed ID: 21562740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Application of the ultra micro analytical system (SUMA) technology for the detection of urinary hCG in antidoping control".
    Martinez Brito D; Bueno Fis E; Fiallo Fernandez T; Torres Castellanos M; Correa Vidal MT; Montes De Oca Porto R
    J Immunoassay Immunochem; 2018; 39(6):672-686. PubMed ID: 30346873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the instability of the isoelectric focusing patterns of erythropoietin in urine.
    Belalcazar V; Gutiérrez Gallego R; Llop E; Segura J; Pascual JA
    Electrophoresis; 2006 Nov; 27(22):4387-95. PubMed ID: 17054082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-doping testing at the 2008 European football championship.
    Vouillamoz M; Thom C; Grisdale R; Saugy M; Giraud S; Robinson N; Gmeiner G; Geisendorfer T
    Drug Test Anal; 2009 Nov; 1(11-12):485-93. PubMed ID: 20355163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of the administration of human erythropoietin (HuEPO) to canines.
    Bartlett C; Clancy GJ; Cowan DA; Healy JF
    J Anal Toxicol; 2006; 30(9):663-9. PubMed ID: 17137526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.